Why can’t the pharmaceutical companies
The United States is on the verge of a solar boom that could provide 4.3 percent of the nation’s electricity by 2020, according to a new report from Bloomberg New Energy Finance.
There’s just a 12-figure catch: Investors need to put $100 billion into the solar industry to keep the generation of solar electricity growing by 42 percent a year for the next decade to expand capacity from the current 1.4 gigawatts to 44 gigawatts
directly fund sponsor desert wind farms?
Federal prosecutors in Boston yesterday said British drug giant GlaxoSmithKline PLC agreed to pay $750 million to settle civil and criminal charges that it made and sold adulterated drugs, including the antidepressant Paxil, to Medicaid and other government payers
The settlement, one of the largest ever in a health care fraud case, burnished the reputation of the US attorney’s office in Boston as the premier federal office for investigating health care fraud. It has been responsible for recovering about $6 billion in health care fines and claims in the past decade, about 25 percent of all recoveries nationally.
If you think I’ve got it backwards, GlaxosmithKline’s share price only went down .14 (fourteen cents!) on news of the settlement.